Text

SCIENCES LESSONS: WHAT THE BUSINESS OF BIOTECH TAUGHT ME ABOUT MANAGEMENT

---

Widely regarded as the most innovative, successful biotech firm ever, Amgen led its industry in revenue and sales growth in 2007. Top magazines including Fortune and Industry Week have repeatedly named it one of America's best companies to work for.

In Science Lessons, Gordon Binder—CEO and chairman during 1988-2000—describes Amgen's climb to success. Revealing the highs and lows it experienced in the race to develop blockbuster drugs, he takes readers from the time Amgen had just three months of capital in the bank and no viable products in the pipeline to its spectacular success. The turning point? The 1989 launch of Epogen, which dramatically helped kidney dialysis patients suffering from debilitating anemia. Other landmark drugs, including Neupogen, would follow.

Through engaging anecdotes and cogent insights, Binder weaves a fascinating tale while offering his unique brand of practical management advice. Using the principals of the scientific method, he shares his recommendations for tackling pressing business challenges such as managing creative employees, navigating the IPO process, and protecting intellectual property.

This colorful first-person account showcases the visionary science and daring business strategy that made Amgen great—offering valuable lessons for all companies.

---

Availability

10001325

338.7 BIN s

RLC MM (Rak Buku Umum)

Available

Detail Information

Series Title

-

Statement of Responsibility

Gordon Binder

Call Number

338.7 BIN s

Publisher

Massachusetts : Harvard Business Press., 2008

Collation

viii, 292 p. : ill ; 21cm.

Language

English

ISBN/ISSN

978-1-59139-861-5

Classification

338.7

Content Type

-

Edition

-

Subject(s)

Buku Umum
Social Sciences
Business Enterprise
Social Economics

Specific Detail Info

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment